A new study found hospital participation in 5 common medical bundles under the Bundled Payments for Care Improvement initiative was not associated with significant changes in Medicare payments, clinical complexity, length of stay, emergency department use, hospital readmission, or mortality.
Previous research revealed the Bundled Payments for Care Improvement (BPCI) initiative, launched by the Center for Medicare and Medicaid Innovation (CMMI) in 2013, was associated with reductions in Medicare payments for total joint replacement; however, a new study found hospital participation in 5 common medical bundles under BPCI was not associated with significant changes in Medicare payments, clinical complexity, length of stay, emergency department use, hospital readmission, or mortality.
The study, published in the New England Journal of Medicine, collected data from Medicare claims from 2013 through 2015 in order to identify admissions for the most commonly selected medical conditions in BPCI, including congestive heart failure (CHF), pneumonia, chronic obstructive pulmonary disease (COPD), sepsis, and acute myocardial infarction (AMI).
The researchers then evaluated the changes in standardized Medicare payments per episode of care (hospitalization and 90 days after discharge) for each condition at BPCI hospitals and compared the data to matched control hospitals.
“BPCI is a voluntary program, and hospitals that choose to participate may select from several models,” the authors explained. "Under model 2, the most popular model among hospitals, participating hospitals assume accountability for the costs of all care within 30, 60, or 90 days after hospitalization for 1 or more of 48 conditions that together account for approximately 70% of Medicare spending. Hospitals may choose the conditions and the time window. If cost targets are achieved, participating hospitals keep a portion of the savings; if cost targets are exceeded, participating hospitals reimburse Medicare for part of the difference.”
There was a total of 125 hospitals for CHF that participated in BPCI, 105 for pneumonia, 101 for COPD, 88 for sepsis, and 73 hospitals for AMI. At baseline, the researchers found the average Medicare payment per episode of care among the 5 conditions was $24,280 and decreased to $23,993 during the intervention period. Control hospitals, at baseline, had an average payment for all episodes of $23,901 and this decreased to $23,503 during the intervention period.
The study noted that changes in clinical complexity, length of stay, emergency department use, or readmission within 30 or 90 days after discharge, or death within 30 or 90 days after admission did not differ significantly between the intervention and control hospitals.
“Bundling of services to encourage more efficient care has great face validity and enjoys bipartisan support,” the authors concluded. “For such bundling to work for medical conditions, however, more time, new care strategies and partnerships, or additional incentives may be required.”
Reference
Joynt Maddox KE, Orav EJ, Zheng J, Epstein AM. Evaluation of Medicare's Bundled Payments Initiative for medical conditions. N Engl J Med. 2018; 379(3):260-269. doi: 10.1056/NEJMsa1801569.
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen
What We’re Reading: HHS' Funding Flat; Mifepristone Safety; Insulin Shortage
March 25th 2024Flat funding for Health and Human Services (HHS) leaves critical health initiatives stagnant; Supreme Court weighs tightening regulations on abortion pill; manufacturing delay sparks access concerns for insulin medication.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
CMS is highly likely to negotiate the price of the obesity medication semaglutide in the coming years; many health care providers are trying to determine whether their cyberattack insurance will help cover their losses after the Change Healthcare hack; the US life expectancy increased for the first time in 2 years.
Read More